Andrew Galbraith

Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years

Anne Keogh, Peter Ruygrok, Phillip Spratt et al. · Circulation · 2004 · 455 citations

Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

Rajiv Khanna, Scott C. Bell, Martina A. Sherritt et al. · Proceedings of the National Academy of Sciences · 1999 · 330 citations

Diastolic ventricular interaction in chronic heart failure

J. Atherton, Thomas Moore, Suhas S. Lele et al. · The Lancet · 1997 · 219 citations

Heart Failure, Chronic Heart Failure, Cardiovascular Disease +6

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure11Coenzyme Q and matching placebo tablets were supplied by Health World Limited, Brisbane, Australia.

Paul S. Watson, G. Scalia, Andrew Galbraith et al. · Journal of the American College of Cardiology · 1999 · 150 citations

Cardiomyopathy, Heart Failure, Placebo Tablets +10

Aortic valve infection. Risk factors for death and recurrent endocarditis after aortic valve replacement.

David C. McGiffin, Andrew Galbraith, Geoffrey J. McLachlan et al. · PubMed · 1992 · 133 citations

Heart Failure, Healed Endocarditis, Aortic Diseases +17